Drug intelligence / Profile preview

nooLVL

Development stage
Unknown
Lead developer
Nutrition21
Modality
Small Molecules
Administration
Oral
01

Overview

nooLVL is a patented, non-stimulant dietary supplement ingredient developed by Nutrition21, specifically designed to enhance cognitive performance, focus, and accuracy. It is a unique complex consisting of Bonded Arginine Silicate (Nitrosigine) combined with an additional optimized dose of Inositol. The ingredient functions by significantly increasing nitric oxide levels, which promotes vasodilation and enhances blood flow to the brain, thereby improving the delivery of oxygen and essential nutrients. The inositol component further supports cognitive health by acting as a precursor for secondary messengers in neurotransmitter signaling pathways involved in learning and memory. Originally targeted at the esports and gaming market, clinical studies have demonstrated that nooLVL can improve focus, concentration, visual attention, and reaction time within as little as 15 minutes of consumption without adversely affecting heart rate or blood pressure.

Brand names
nooLVL
Other names
Bonded Arginine Silicate with InositolNutrition21 nooLVLNutrition-21 nooLVLNutrition 21 nooLVLNitrosigine with Inositol
02

Targets

NOS1 (nNOS)

Beyond the preview

Go deeper on nooLVL.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on nooLVL.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call